Cargando…
GALNT2 sustains glioma stem cells by promoting CD44 expression
Glioblastoma (GBM) is the most prevalent and malignant brain tumor and is highly resistant to currently available treatment. In this study, we reveal that polypeptide N-acetylgalactosaminyltransferase 5 (GALNT2) expression level was elevated in GBM, IDH1 wildtype glioma, and GBM stem cells (GSCs). G...
Autores principales: | Liu, Yingying, Chen, Peisheng, Xu, Liufei, Wang, Bo, Zhang, Shengping, Wang, Xiangpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085609/ https://www.ncbi.nlm.nih.gov/pubmed/37000153 http://dx.doi.org/10.18632/aging.204609 |
Ejemplares similares
-
High expression of GALNT7 promotes invasion and proliferation of glioma cells
por: Hua, Shi, et al.
Publicado: (2018) -
GALNT1 Enhances Malignant Phenotype of Gastric Cancer via Modulating CD44 Glycosylation to Activate the Wnt/β-catenin Signaling Pathway
por: Zhang, Junchang, et al.
Publicado: (2022) -
CD44 expressed by myeloid cells promotes glioma invasion
por: Ivanova, Ekaterina L., et al.
Publicado: (2022) -
CD44 promotes the migration of bone marrow-derived mesenchymal stem cells toward glioma
por: YIN, QIANG, et al.
Publicado: (2016) -
Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”
por: Hou, Chongxian, et al.
Publicado: (2020)